Description

An infiltrating ductal carcinoma with extensive ductal carcinoma in situ (DCIS) may have a higher risk of recurrence following conservative management with lumpectomy. This probably is associated with the risk of residual DCIS remaining in the breast. The risk of treatment failure is greater if the DCIS is high grade.


 

Synonym: invasive ductal carcinoma with predominant intraductal component (WHO)

 

Features of infiltrating carcinoma with extensive DCIS:

(1) presence of invasive carcinoma

(2) a significant proportion of the region involved by the invasive carcinoma consists of DCIS.

(3) DCIS is present beyond the area of invasive tumor.

 

where:

• The criteria for what constitutes a significant proportion of the DCIS is not clear cut.

• Tavassoli refers to DCIS comprising > 25% of the invasive carcinoma, but this would also include a focus of DCIS with microinvasion.

• Schnitt et al use DCIS as "moderate or marked" within the tumor.

• Matsukuma et al reported that tumors with DCIS and less than 20% invasion had better survivals than those with >= 20%. The problem here is determining the relative volume for those tumors that are not discreet lesions.

• In addition, the amount of DCIS beyond the area of invasion is somewhat subjective. A single small duct would probably not qualify.

 

Recurrence is more likely if:

(1) the margins of excision are positive

(2) the DCIS is Tavassoli Grade III/III (Schnitt et al)

 

Limitations:

• There is likely to be some inter-pathologist variation in the use of this term.

• In the cases I have seen, a key factor is whether I think the process is an infiltrating carcinoma with DCIS, or DCIS with infiltrating carcinoma.

 


To read more or access our algorithms and calculators, please log in or register.